COAG vs MESO: stock comparison and AI forecast
Hemab Therapeutics Holdings, Inc. (COAG) and Mesoblast Ltd (MESO) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
COAG Hemab Therapeutics Holdings, Inc.
- Price
- $41.18 +56.6% · 6M
- Market Cap
- $1.92B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MESO Mesoblast Ltd
- Price
- $14.54 -9.1% · 6M
- Market Cap
- $1.86B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- COAG and MESO have similar market capitalizations ($1.92B and $1.86B).
- Over the last six months COAG returned +56.6% and MESO -9.1%.
- MESO carries 0.36 times debt per unit of equity, against 0.03 times for COAG.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | COAG | MESO |
|---|---|---|
| Market Cap | $1.92B | $1.86B |
| P/B Ratio | 4.23x | – |
| EPS | – | $-0.25 |
| Book Value/Share | $9.72 | – |
| Revenue/Share | – | $0.61 |
Profitability & Margins
| Metric | COAG | MESO |
|---|---|---|
| EBT Margin | – | -357.5% |
| Tax Rate | – | -0.3% |
Financial Health
| Metric | COAG | MESO |
|---|---|---|
| Current Ratio | 35.85x | 1.58x |
| Quick Ratio | – | 1.41x |
| D/E Ratio | 0.03x | 0.36x |
| Financial Leverage | 1.03x | 1.36x |
| Working Capital | $451M | $74M |
Cash Flow
| Metric | COAG | MESO |
|---|---|---|
| Operating Cash Flow | – | -$149M |
Operational Efficiency
| Metric | COAG | MESO |
|---|---|---|
| Asset Turnover | – | 0.10x |
| Receivables Turnover | – | 1.8x |
| Fixed Assets Turnover | – | 43.3x |
| Days Sales Outstanding | – | 204 days |
Income Statement
| Metric | COAG | MESO |
|---|---|---|
| Total Revenue | – | $78M |
| R&D Expense | – | $127M |
Dividend & Shareholder Information
| Metric | COAG | MESO |
|---|---|---|
| Shares Outstanding | 47M | 128M |
COAG vs MESO: stock comparison and AI forecast
Which is bigger, COAG or MESO?
COAG and MESO have similar market capitalizations ($1.92B and $1.86B).
Which stock performed better over the last six months, COAG or MESO?
Over the last six months COAG returned +56.6% and MESO -9.1%.
Which one does Intratio's AI model rank higher, COAG or MESO?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.